Importance of IL-10 for CTLA-4-Mediated Inhibition of Tumor-Eradicating Immunity

Journal of Immunology - United States
doi 10.4049/jimmunol.172.3.1449
Full Text
Abstract

Available in full text

Date
Authors
Publisher

The American Association of Immunologists

Related search

Stable IL-10: A New Therapeutic That Promotes Tumor Immunity

Cancer Cell
Cancer ResearchOncologyCell Biology
2011English

Enhancement of Anti-Tumor Immunity Through Local Modulation of CTLA-4 and GITR by Dendritic Cells

European Journal of Immunology
AllergyImmunology
2011English

Antibody-Mediated Inhibition of MICA and MICB Shedding Promotes NK Cell–driven Tumor Immunity

Science
MultidisciplinaryPhilosophy of ScienceHistory
2018English

CTLA-4 Blockade Synergizes With Cryoablation to Mediate Tumor Rejection

OncoImmunology
OncologyAllergyImmunology
2012English

CTLA-4 Blockade Boosts the Expansion of Tumor-Reactive CD8+ Tumor-Infiltrating Lymphocytes in Ovarian Cancer

Scientific Reports
Multidisciplinary
2020English

Ctla-4 (Cd152)

Science-Business eXchange
2010English

Impairment of NKG2D-Mediated Tumor Immunity by TGF-β

Frontiers in Immunology
AllergyImmunology
2019English

Potential Involvement of Monocyte Chemoattractant Protein (MCP)-1/CCL2 in IL-4-mediated Tumor Immunity Through Inducing Dendritic Cell Migration Into the Draining Lymph Nodes

International Immunopharmacology
AllergyImmunologyPharmacology
2003English

Importance of IL-10 and IL-17 Cytokines in Human Asthma as Studied by ELISPOT

International Journal of Medicine and Biomedical Research
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy